• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两个新的 ANK1 失功能突变与中国人遗传性血影细胞增多症家系相关。

Two novel ANK1 loss-of-function mutations in Chinese families with hereditary spherocytosis.

机构信息

Department of Biochemistry and Molecular Biology, Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China.

出版信息

J Cell Mol Med. 2019 Jun;23(6):4454-4463. doi: 10.1111/jcmm.14343. Epub 2019 Apr 23.

DOI:10.1111/jcmm.14343
PMID:31016877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6533472/
Abstract

Hereditary spherocytosis (HS) is the most common inherited haemolytic anaemia disorder. ANK1 mutations account for most HS cases, but pathogenicity analysis and functional research have not been widely performed for these mutations. In this study, in order to confirm diagnosis, gene mutation was screened in two unrelated Chinese families with HS by a next-generation sequencing (NGS) panel and then confirmed by Sanger sequencing. Two novel heterozygous mutations (c.C841T, p.R281X and c.T290G, p.L97R) of the ANK1 gene were identified in the two families respectively. Then, the pathogenicity of the two new mutations and two previously reported ANK1 mutations (c.C648G, p.Y216X and c.G424T, p.E142X) were studied by in vitro experiments. The four mutations increased the osmotic fragility of cells, reduced the stabilities of ANK1 proteins and prevented the protein from localizing to the plasma membrane and interacting with SPTB and SLC4A1. We classified these four mutations into disease-causing mutations for HS. Thus, conducting the same mutation test and providing genetic counselling for the two families were meaningful and significant. Moreover, the identification of two novel mutations enriches the ANK1 mutation database, especially in China.

摘要

遗传性球形红细胞增多症(HS)是最常见的遗传性溶血性贫血疾病。ANK1 基因突变占大多数 HS 病例,但这些突变的致病性分析和功能研究尚未广泛开展。在这项研究中,为了明确诊断,通过下一代测序(NGS)panel 对两个无血缘关系的 HS 中国家庭进行了基因突变筛查,然后通过 Sanger 测序进行了确认。在这两个家庭中分别鉴定出 ANK1 基因的两个新的杂合突变(c.C841T,p.R281X 和 c.T290G,p.L97R)。然后,通过体外实验研究了这两个新突变和两个先前报道的 ANK1 突变(c.C648G,p.Y216X 和 c.G424T,p.E142X)的致病性。这四个突变增加了细胞的渗透脆性,降低了 ANK1 蛋白的稳定性,并阻止了蛋白定位于质膜并与 SPTB 和 SLC4A1 相互作用。我们将这四个突变归类为 HS 的致病突变。因此,对这两个家庭进行相同的突变检测和遗传咨询具有重要意义。此外,两个新突变的鉴定丰富了 ANK1 突变数据库,特别是在中国。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/9be7c38f2bd0/JCMM-23-4454-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/b70f0dc69f7c/JCMM-23-4454-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/7f99b40b5972/JCMM-23-4454-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/74185107de78/JCMM-23-4454-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/0e5195e526a4/JCMM-23-4454-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/9be7c38f2bd0/JCMM-23-4454-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/b70f0dc69f7c/JCMM-23-4454-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/7f99b40b5972/JCMM-23-4454-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/74185107de78/JCMM-23-4454-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/0e5195e526a4/JCMM-23-4454-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/061e/6533472/9be7c38f2bd0/JCMM-23-4454-g005.jpg

相似文献

1
Two novel ANK1 loss-of-function mutations in Chinese families with hereditary spherocytosis.两个新的 ANK1 失功能突变与中国人遗传性血影细胞增多症家系相关。
J Cell Mol Med. 2019 Jun;23(6):4454-4463. doi: 10.1111/jcmm.14343. Epub 2019 Apr 23.
2
Exome sequencing confirms molecular diagnoses in 38 Chinese families with hereditary spherocytosis.外显子组测序在 38 个遗传性球形红细胞增多症的中国家系中确认了分子诊断。
Sci China Life Sci. 2018 Aug;61(8):947-953. doi: 10.1007/s11427-017-9232-6. Epub 2018 Mar 19.
3
Identification of new mutations in patients with hereditary spherocytosis by next-generation sequencing.采用下一代测序技术鉴定遗传性球形红细胞增多症患者的新突变。
J Hum Genet. 2020 Apr;65(4):427-434. doi: 10.1038/s10038-020-0724-z. Epub 2020 Jan 24.
4
Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis.遗传性球形红细胞增多症中ANK1和SPTB基因的突变特征
Clin Genet. 2016 Jul;90(1):69-78. doi: 10.1111/cge.12749. Epub 2016 Mar 15.
5
Targeted next-generation sequencing identified a novel mutation associated with hereditary spherocytosis in a Chinese family.靶向二代测序在中国一个家族中鉴定出一个与遗传性球形红细胞增多症相关的新突变。
Hematology. 2019 Dec;24(1):583-587. doi: 10.1080/16078454.2019.1650873.
6
Clinical manifestation and phenotypic analysis of novel gene mutation in 28 Chinese children with hereditary spherocytosis.遗传性球形红细胞增多症 28 例患儿新基因突变的临床表型及分析
Mol Genet Genomic Med. 2021 Apr;9(4):e1577. doi: 10.1002/mgg3.1577. Epub 2021 Feb 23.
7
A Novel Mutation in Gene Identified through Targeted Next-Generation Sequencing in a Neonate with Hereditary Spherocytosis.通过靶向下一代测序在遗传性球形红细胞增多症新生儿中鉴定出的基因新突变。
Ann Clin Lab Sci. 2021 Jan;51(1):136-139.
8
Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte.韩国遗传性球形红细胞增多症的多基因靶序列分子诊断:与渗透脆性试验和球形红细胞存在相匹配。
Orphanet J Rare Dis. 2019 May 23;14(1):114. doi: 10.1186/s13023-019-1070-0.
9
Targeted next-generation sequencing identifies novel deleterious variants in ANK1 gene causing severe hereditary spherocytosis in Indian patients: expanding the molecular and clinical spectrum.靶向二代测序在印度患者中鉴定出ANK1基因导致严重遗传性球形红细胞增多症的新的有害变异:拓展分子和临床谱
Mol Genet Genomics. 2023 Mar;298(2):427-439. doi: 10.1007/s00438-022-01984-1. Epub 2023 Jan 4.
10
Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.应用靶向下一代测序技术解析印度遗传性球形红细胞增多症家系的分子异质性:首个南亚研究。
Br J Haematol. 2020 Mar;188(5):784-795. doi: 10.1111/bjh.16244. Epub 2019 Oct 10.

引用本文的文献

1
Genotype clinical phenotype analysis of 35 cases of hereditary spherocytosis in children.35例儿童遗传性球形红细胞增多症的基因型与临床表型分析
Front Pediatr. 2025 Aug 20;13:1650295. doi: 10.3389/fped.2025.1650295. eCollection 2025.
2
Identification and functional analysis of novel SPTB and ANK1 mutations in hereditary spherocytosis patients.遗传性球形红细胞增多症患者中新型 SPTB 和 ANK1 突变的鉴定和功能分析。
Sci Rep. 2024 Nov 9;14(1):27362. doi: 10.1038/s41598-024-78622-w.
3
Genetic mutation analysis of hereditary spherocytosis in Guangxi Zhuang Autonomous Region.

本文引用的文献

1
Exome sequencing confirms molecular diagnoses in 38 Chinese families with hereditary spherocytosis.外显子组测序在 38 个遗传性球形红细胞增多症的中国家系中确认了分子诊断。
Sci China Life Sci. 2018 Aug;61(8):947-953. doi: 10.1007/s11427-017-9232-6. Epub 2018 Mar 19.
2
Molecular Genetic Mechanisms of Hereditary Spherocytosis: Current Perspectives.遗传性球形红细胞增多症的分子遗传机制:当前观点
Acta Haematol. 2018;139(1):60-66. doi: 10.1159/000486229. Epub 2018 Jan 22.
3
Review of Clinical Next-Generation Sequencing.临床新一代测序综述
广西壮族自治区遗传性球形红细胞增多症的基因突变分析。
J Hematop. 2023 Jun;16(2):95-101. doi: 10.1007/s12308-023-00545-8. Epub 2023 May 5.
4
Spherocytosis-Related L1340P Mutation in Ankyrin Affects Its Interactions with Spectrin.锚蛋白中与球形红细胞增多症相关的L1340P突变影响其与血影蛋白的相互作用。
Life (Basel). 2023 Jan 4;13(1):151. doi: 10.3390/life13010151.
5
Targeted next-generation sequencing identifies a novel nonsense mutation in ANK1 for hereditary spherocytosis: A case report.靶向二代测序鉴定出遗传性球形红细胞增多症ANK1基因中的一个新的无义突变:病例报告
World J Clin Cases. 2022 May 26;10(15):4923-4928. doi: 10.12998/wjcc.v10.i15.4923.
6
Severe hyperbilirubinemia in a neonate with hereditary spherocytosis due to a ankyrin mutation: A case report.因锚蛋白突变导致遗传性球形红细胞增多症的新生儿严重高胆红素血症:一例报告。
World J Clin Cases. 2021 Jul 6;9(19):5245-5251. doi: 10.12998/wjcc.v9.i19.5245.
Arch Pathol Lab Med. 2017 Nov;141(11):1544-1557. doi: 10.5858/arpa.2016-0501-RA. Epub 2017 Aug 7.
4
Novel mutations in patients with hereditary red blood cell membrane disorders using next-generation sequencing.利用下一代测序技术对遗传性红细胞膜疾病患者的新型突变进行研究。
Gene. 2017 Sep 5;627:556-562. doi: 10.1016/j.gene.2017.07.009. Epub 2017 Jul 8.
5
Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis.遗传性球形红细胞增多症中ANK1和SPTB基因的突变特征
Clin Genet. 2016 Jul;90(1):69-78. doi: 10.1111/cge.12749. Epub 2016 Mar 15.
6
Evaluation of a Flow-Cytometric Osmotic Fragility Test for Hereditary Spherocytosis in Chinese Patients.流式细胞术检测中国患者遗传性球形红细胞增多症渗透脆性试验的评估
Acta Haematol. 2016;135(2):88-93. doi: 10.1159/000438738. Epub 2015 Oct 28.
7
A systematic review of hereditary spherocytosis reported in Chinese biomedical journals from 1978 to 2013 and estimation of the prevalence of the disease using a disease model.一项对1978年至2013年中国生物医学期刊报道的遗传性球形红细胞增多症的系统评价以及使用疾病模型对该疾病患病率的估计。
Intractable Rare Dis Res. 2015 May;4(2):76-81. doi: 10.5582/irdr.2015.01002.
8
ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders.国际血液学标准化委员会(ICSH)关于非免疫性遗传性红细胞膜疾病实验室诊断的指南。
Int J Lab Hematol. 2015 Jun;37(3):304-25. doi: 10.1111/ijlh.12335. Epub 2015 Mar 18.
9
A novel L1340P mutation in the ANK1 gene is associated with hereditary spherocytosis?ANK1基因中的一种新型L1340P突变与遗传性球形红细胞增多症有关吗?
Br J Haematol. 2014 Oct;167(2):269-71. doi: 10.1111/bjh.12960. Epub 2014 Jun 5.
10
Flow cytometric analysis of red blood cell osmotic fragility.红细胞渗透脆性的流式细胞仪分析
J Lab Autom. 2014 Oct;19(5):483-7. doi: 10.1177/2211068214532254. Epub 2014 Apr 21.